Investigational Drug Information for Bufotenin
✉ Email this page to a colleague
What is the development status for investigational drug Bufotenin?
Bufotenin is an investigational drug.
There have been 5 clinical trials for Bufotenin.
The most recent clinical trial was a Phase 1 trial, which was initiated on April 6th 2023.
The most common disease conditions in clinical trials are Depressive Disorder, Depression, and Disease. The leading clinical trial sponsors are GH Research Ireland Limited and [disabled in preview].
There are eighty-six US patents protecting this investigational drug and four hundred and ninety-six international patents.
Summary for Bufotenin
| US Patents | 86 |
| International Patents | 496 |
| US Patent Applications | 424 |
| WIPO Patent Applications | 285 |
| Japanese Patent Applications | 115 |
| Clinical Trial Progress | Phase 1 (2023-04-06) |
| Vendors | 31 |
Recent Clinical Trials for Bufotenin
| Title | Sponsor | Phase |
|---|---|---|
| Phase 2 Clinical Trial of GH001 in Bipolar II Disorder | GH Research Ireland Limited | Phase 2 |
| A Trial of GH001 in Patients With Treatment-resistant Depression | GH Research Ireland Limited | Phase 2 |
| Phase 2 Clinical Trial of GH001 in Postpartum Depression | GH Research Ireland Limited | Phase 2 |
Clinical Trial Summary for Bufotenin
Top disease conditions for Bufotenin
Top clinical trial sponsors for Bufotenin
US Patents for Bufotenin
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Bufotenin | ⤷ Try a Trial | Pharmaceutical compositions resistant to abuse | EGALET LTD. (London, GB) | ⤷ Try a Trial |
| Bufotenin | ⤷ Try a Trial | Abuse-deterrent controlled release formulations | Patheon Softgels Inc. (High Point, NC) | ⤷ Try a Trial |
| Bufotenin | ⤷ Try a Trial | Opioid and attention deficit hyperactivity disorder medications possessing abuse deterrent and anti-dose dumping safety features | Pisgah Laboratories, Inc. (Pisgah Forest, NC) | ⤷ Try a Trial |
| Bufotenin | ⤷ Try a Trial | Enteric soft capsule compositions | Patheon Softgels Inc. (High Point, NC) | ⤷ Try a Trial |
| Bufotenin | ⤷ Try a Trial | Non-burst releasing pharmaceutical composition | Patheon Softgels, Inc. (High Point, NC) | ⤷ Try a Trial |
| Bufotenin | ⤷ Try a Trial | Lateral flow devices and methods of manufacture and use | CAREHEALTH AMERICA CORPORATION (El Monte, CA) | ⤷ Try a Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Bufotenin
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Bufotenin | Australia | AU2010211376 | 2029-02-06 | ⤷ Try a Trial |
| Bufotenin | Australia | AU2013257533 | 2029-02-06 | ⤷ Try a Trial |
| Bufotenin | Canada | CA2751627 | 2029-02-06 | ⤷ Try a Trial |
| Bufotenin | Denmark | DK2393487 | 2029-02-06 | ⤷ Try a Trial |
| Bufotenin | European Patent Office | EP2393487 | 2029-02-06 | ⤷ Try a Trial |
| Bufotenin | European Patent Office | EP3184105 | 2029-02-06 | ⤷ Try a Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
